Search Results - "Brott, D. A."

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Donor-to-donor variability in the expansion potential of human bone marrow cells is reduced by accessory cells but not by soluble growth factors by Koller, M R, Manchel, I, Brott, D A, Palsson Bø

    Published in Experimental hematology (01-11-1996)
    “…Clinical trials assessing the utility of cultured hematopoietic cells for the support of patients receiving high-dose chemotherapy are beginning. Although many…”
    Get more information
    Journal Article
  2. 2

    Flow cytometric characterization of perfused human bone marrow cultures: Identification of the major cell lineages and correlation with the CFU‐GM assay by Brott, D. A., Maher, R. J., Parrish, C. R., Richardson, R. J., Smith, A. K.

    Published in Cytometry. Part A (01-05-2003)
    “…Background Prolific cultures of human bone marrow mononuclear cells (BM MNCs) were recently developed that include a full spectrum of hematopoietic and…”
    Get full text
    Journal Article
  3. 3

    Bacterial lipopolysaccharide, phorbol myristate acetate, and muramyl dipeptide stimulate the expression of a human monocyte surface antigen, Mo3e by Todd, RF, 3d, Alvarez, PA, Brott, DA, Liu, DY

    Published in The Journal of immunology (1950) (01-12-1985)
    “…Exposure of mononuclear phagocytes to bacterial lipopolysaccharide (LPS), phorbol myristate acetate (PMA), or muramyl dipeptide (MDP) is known to stimulate a…”
    Get full text
    Journal Article
  4. 4

    Current status and future directions for diagnostic markers of drug-induced vascular injury by Brott, D A, Jones, H B, Gould, S, Valentin, J P, Evans, G, Richardson, R J, Louden, C

    “…Recently, there has been an increased incidence of vascular toxicity in pre-clinical toxicology studies. This is of concern because of the uncertain relevance…”
    Get more information
    Journal Article
  5. 5
  6. 6

    Cell cycle dependent distribution of proliferating cell nuclear antigen/cyclin and cdc2-kinase in mouse T-lymphoma cells by Brott, D A, Alvey, J D, Bleavins, M R, de la Iglesia, F A, Lalwani, N D

    Published in Journal of cellular biochemistry (01-07-1993)
    “…The aim of the present study was to investigate bromodeoxyuridine (BrdU) uptake and coordinated distribution of proliferating cell nuclear antigen (PCNA) and…”
    Get more information
    Journal Article
  7. 7

    Flow cytometric characterization of lymphocyte subpopulations in the cynomolgus monkey (Macaca fascicularis) by Bleavins, M R, Brott, D A, Alvey, J D, de la Iglesia, F A

    Published in Veterinary immunology and immunopathology (01-06-1993)
    “…Characterization of immune cell subpopulations in the cynomolgus monkey was performed using a direct immunofluorescence technique adaptable for routine and…”
    Get more information
    Journal Article
  8. 8

    Differential analysis of animal bone marrow by flow cytometry by Martin, Ronald A., Brott, David A., Zandee, Joyce C., McKeel, Mildred J.

    Published in Cytometry (New York, N.Y.) (1992)
    “…A simple procedure was developed for rapid analysis of animal bone marrow by flow cytometry using the lipophilic cationic dye 3,3′‐dihexyloxacarbocyanine…”
    Get full text
    Journal Article
  9. 9

    Regulation of Human Monocyte Surface Antigen Expression. I. Up-Modulation of Mo3e Antigen Expression on U-937 and HL-60 Cells Stimulated by Pharmacologic Activators of Protein Kinase C by Todd, Robert F., Bury, Martin J., Alvarez, Patti A., Brott, David A., Liu, David Y.

    Published in Blood (01-11-1986)
    “…Mo3e is a protein (p 50,80) that is expressed on the surface of human monocytic cells after exposure in vitro to soluble activating factors that include…”
    Get full text
    Journal Article
  10. 10

    Are Laboratory Parameter (Biomarker) Values Similar to the Healthy Volunteer Reference Range in Individuals with Diabetes by Brott, David A, Goodman, Michael J, Hermann, Richard P, Anderson, Isobel, Kiazand, Alexandre

    Published in Drug design, development and therapy (01-01-2020)
    “…Identification of laboratory parameter clinical safety signals depends on the terminology and scoring criteria. Grade 1 scoring criteria in the Common…”
    Get full text
    Journal Article
  11. 11

    Characterization of renal biomarkers for use in clinical trials: biomarker evaluation in healthy volunteers by Brott, David A, Adler, Scott H, Arani, Ramin, Lovick, Susan C, Pinches, Mark, Furlong, Stephen T

    Published in Drug design, development and therapy (01-01-2014)
    “…Several preclinical urinary biomarkers have been qualified and accepted by the health authorities (US Food and Drug Administration, European Medicines Agency,…”
    Get full text
    Journal Article
  12. 12

    Are laboratory parameter (biomarker) values similar to the healthy volunteer reference range in all patient populations? by Brott, David A, Goodman, Michael J, Hermann, Richard P, Merz, Michael, Calvo, Roser, Poorkhalkali, Nadereh, Kiazand, Alexandre

    Published in Drug design, development and therapy (01-01-2018)
    “…Liver biomarkers alanine aminotransferase (ALT) and bilirubin in patients with hepatitis are above the healthy volunteer reference range (HVRR) at baseline…”
    Get full text
    Journal Article
  13. 13

    Characterization of renal biomarkers for use in clinical trials: effect of preanalytical processing and qualification using samples from subjects with diabetes by Brott, David A, Furlong, Stephen T, Adler, Scott H, Hainer, James W, Arani, Ramin B, Pinches, Mark, Rossing, Peter, Chaturvedi, Nish

    Published in Drug design, development and therapy (01-01-2015)
    “…Identifying the potential for drug-induced kidney injury is essential for the successful research and development of new drugs. Newer and more sensitive…”
    Get full text
    Journal Article
  14. 14

    Immunofluorescence quantitation of stromelysin in human synovial fibroblasts by confocal laser scanning microscopy by Baragi, V M, Brott, D A, Qiu, L, Conroy, M C, Lalwani, N D

    Published in Laboratory investigation (01-04-1995)
    “…Elevated levels of stromelysin have been reported in humans with osteoarthritis and rheumatoid arthritis, as well as in animal models of arthritis. However, a…”
    Get more information
    Journal Article
  15. 15
  16. 16

    flt-3 ligand is more potent than c-kit ligand for the synergistic stimulation of ex vivo hematopoietic cell expansion by Koller, M R, Oxender, M, Brott, D A, Palsson, B O

    Published in Journal of hematotherapy (01-10-1996)
    “…The c-kit and flt-3 tyrosine kinase receptors are expressed on primitive hematopoietic cells, and ligands for both receptors have been cloned. In this study,…”
    Get more information
    Journal Article